Search for Clinical Trial Results

Sponsored By

Anaplastic Plasmacytoma - 139 Studies Found

Status Study
Completed Study Name: Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Date: 2007-05-23
Interventions:
  • Drug: bortezomib
  • Other: immunologic techni
Active, not recruiting Study Name: Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan, Melphalan, and Autologous Peripheral Stem Cell Transplant in Treating Patients With Previously Treated Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Date: 2007-05-23
Interventions:
  • Biological: rituximab 375 mg/m
Completed Study Name: Melphalan, Prednisone, and Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Date: 2007-05-23
Interventions:
  • Drug: lenalidomide

Completed Study Name: Interferon Alfa and Interleukin-6 in Treating Patients With Recurrent Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Date: 2007-05-03
Interventions:
  • Biological: recombinant interferon alfa
  • Bi
Completed Study Name: Bortezomib, Doxorubicin Hydrochloride Liposome, and Dexamethasone Followed by Thalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Date: 2007-04-09
Interventions:
  • Drug: bortezomib
  • Drug: dexamethasone
Completed Study Name: Lenalidomide and Vaccine Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Date: 2007-03-07
Interventions:
  • Biological: pneumococcal polyvalent vaccine

Completed Study Name: Bortezomib, Cyclophosphamide, Dexamethasone, and Thalidomide in Treating Patients With Newly Diagnosed, Previously Untreated Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Date: 2007-02-20
Interventions:
  • Drug: bortezomib
  • Drug: cyclophosphamide
Completed Study Name: Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Date: 2007-02-05
Interventions:
  • Drug: Thalidomide 200 mg orall
Completed Study Name: Bortezomib and Dexamethasone in Treating Patients With Multiple Myeloma That Has Relapsed or Has Not Responded to Treatment
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Date: 2006-10-18
Interventions:
  • Drug: bortezomib
  • Drug: dexamethasone
Completed Study Name: Antithymocyte Globulin in Treating Patients Undergoing Stem Cell Transplant for Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Date: 2006-09-19
Interventions: Biological: anti-thymocyte globulin
<<< Previous | Next >>>